In this study, we studied the unique metabolism of ovarian cancer overexpressing SDHA and identified key vulnerabilities of tumors with the SDHA-gain-of-function phenotype that can be exploited for therapeutic benefit. Here, SDHA is linked to ovarian carcinoma.